# Kalaris Therapeutics, Inc.: Form 8-K, filed Feb 12, 2024

- Company: [Kalaris Therapeutics, Inc.](/companies/klrs.md) (CIK 1754068)
- Form: 8-K
- Filed: 2024-02-12
- Accepted by EDGAR: Feb 12, 2024, 16:34 ET
- Period: 2024-02-09
- Accession: 0001193125-24-032160
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1754068/000119312524032160/d764004d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1754068/000119312524032160/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1754068/000119312524032160/d764004d8k.htm

Filed Feb 12, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-032160. Last ingested by Listed: Oct 26, 2026, 17:31 ET. No prices; not investment advice.